{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:58:20Z","timestamp":1761541100682,"version":"3.40.4"},"reference-count":70,"publisher":"Pharmaceutical Society of Japan","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chem. Pharm. Bull.","CHEMICAL & PHARMACEUTICAL BULLETIN"],"published-print":{"date-parts":[[2013]]},"DOI":"10.1248\/cpb.c12-00462","type":"journal-article","created":{"date-parts":[[2012,12,2]],"date-time":"2012-12-02T22:39:21Z","timestamp":1354487961000},"page":"121-124","source":"Crossref","is-referenced-by-count":5,"title":["Pravastatin Inhibits Plaque Rupture and Subsequent Thrombus Formation in Atherosclerotic Rabbits with Hyperlipidemia"],"prefix":"10.1248","volume":"61","author":[{"given":"Gang","family":"Wu","sequence":"first","affiliation":[{"name":"Department of Cardiology, Renmin Hospital of Wuhan University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First Affiliated Hospital of Xiamen University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Renmin Hospital of Wuhan University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Renmin Hospital of Wuhan University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengrong","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First Affiliated Hospital of Xiamen University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Congxin","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Renmin Hospital of Wuhan University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2010.12.010"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2010.12.010"},{"key":"3","doi-asserted-by":"crossref","unstructured":"2) Newby A. C., Johnson J. L., Circ. Res.<\/i>, 97<\/b>, 958–960 (2005).","DOI":"10.1161\/01.RES.0000193565.23357.c0"},{"key":"4","doi-asserted-by":"crossref","unstructured":"2. Newby AC, Johnson JL. Genetic strategies to elucidate the roles of matrix metalloproteinases in atherosclerotic plaque growth and stability. Circ Res.<\/i>, 97, 958–960 (2005).","DOI":"10.1161\/01.RES.0000193565.23357.c0"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0506201102"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0506201102"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000036081.01231.16"},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000036081.01231.16"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1161\/hq1001.097063"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1161\/hq1001.097063"},{"key":"11","doi-asserted-by":"crossref","unstructured":"6) Huang H., Virmani R., Younis H., Burke A. P., Kamm R. D., Lee R. T., Circulation<\/i>, 103<\/b>, 1051–1056 (2001).","DOI":"10.1161\/01.CIR.103.8.1051"},{"key":"12","doi-asserted-by":"crossref","unstructured":"6. Huang H, Virmani R, Younis H, Burke AP, Kamm RD, Lee RT. The impact of calcification on the biomechanical stability of atherosclerotic plaques. Circulation.<\/i>, 103, 1051–1056 (2001).","DOI":"10.1161\/01.CIR.103.8.1051"},{"key":"13","doi-asserted-by":"crossref","unstructured":"7) Moreau M., Brocheriou I., Petit L., Ninio E., Chapman M. J., Rouis M., Circulation<\/i>, 99<\/b>, 420–426 (1999).","DOI":"10.1161\/01.CIR.99.3.420"},{"key":"14","unstructured":"7. Moreau M, Brocheriou I, Petit L, Ninio E, Chapman MJ, Rouis M. Interleukin-8 mediates downregulation of tissue inhibitor of metalloproteinase-1 expression in cholesterol-loaded human macrophages: relevance to stability of atherosclerotic plaque. Circulation.<\/i>, 99, 420–426 (1999)."},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000068646.76823.AE"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000068646.76823.AE"},{"key":"17","doi-asserted-by":"crossref","unstructured":"9) Aikawa M., Rabkin E., Sugiyama S., Voglic S. J., Fukumoto Y., Furukawa Y., Shiomi M., Schoen F. J., Libby P., Circulation<\/i>, 103<\/b>, 276–283 (2001).","DOI":"10.1161\/01.CIR.103.2.276"},{"key":"18","doi-asserted-by":"crossref","unstructured":"9. Aikawa M, Rabkin E, Sugiyama S, Voglic SJ, Fukumoto Y, Furukawa Y, Shiomi M, Schoen FJ, Libby P. An HMG-CoA reductase inhibitor, cerivastatin, suppresses growth of macrophages expressing matrix metalloproteinases and tissue factor in vivo and in vitro. Circulation.<\/i>, 103, 276–283 (2001).","DOI":"10.1161\/01.CIR.103.2.276"},{"key":"19","doi-asserted-by":"crossref","unstructured":"10) Dogné J. M., Hanson J., Pratico D., Trends Pharmacol. Sci.<\/i>, 26<\/b>, 639–644 (2005).","DOI":"10.1016\/j.tips.2005.10.001"},{"key":"20","unstructured":"10. Dogné JM, Hanson J, Pratico D. Thromboxane, prostacyclin and isoprostanes: therapeutic targets in atherogenesis. Trends Pharmacol Sci.<\/i>, 26, 639–644 (2005)."},{"key":"21","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000170888.11669.28"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000170888.11669.28"},{"key":"23","unstructured":"12. Egan KM, Wang M, Fries S, Lucitt MB, Zukas AM, Puré E, Lawson JA, FitzGerald GA. Cyclooxygenases, thromboxane, and atherosclerosis: plaque destabilization by cyclooxygenase-2 inhibition combined with thromboxane receptor antagonism. Circulation.<\/i>, 111, 334–342 (2005)."},{"key":"24","doi-asserted-by":"crossref","unstructured":"12) Egan K. M., Wang M., Fries S., Lucitt M. B., Zukas A. M., Puré E., Lawson J. A., FitzGerald G. A., Circulation<\/i>, 111<\/b>, 334–342 (2005).","DOI":"10.1161\/01.CIR.0000153386.95356.78"},{"key":"25","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200421446"},{"key":"26","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200421446"},{"key":"27","unstructured":"14) Koukkunen H., Penttilä K., Kemppainen A., Halinen M., Penttila I., Rantanen T., Pyörälä K., Ann. Med.<\/i>, 33<\/b>, 37–47 (2001)."},{"key":"28","doi-asserted-by":"crossref","unstructured":"14. Koukkunen H, Penttilä K, Kemppainen A, Halinen M, Penttila I, Rantanen T, Pyörälä K. C-reactive protein, fibrinogen, interleukin-6 and tumour necrosis factor-alpha in the prognostic classification of unstable angina pectoris. Ann Med.<\/i>, 33, 37–47 (2001).","DOI":"10.3109\/07853890109002058"},{"key":"29","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(01)00537-5"},{"key":"30","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(01)00537-5"},{"key":"31","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2010.01.009"},{"key":"32","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2010.01.009"},{"key":"33","unstructured":"17. Jones PH, Farmer JA. Adjunctive interventions in myocardial infarction: the role of statin therapy. Curr Atheroscler Rep.<\/i>, 10, 142–148 (2008)."},{"key":"34","doi-asserted-by":"crossref","unstructured":"17) Jones P. H., Farmer J. A., Curr. Atheroscler. Rep.<\/i>, 10<\/b>, 142–148 (2008).","DOI":"10.1007\/s11883-008-0021-3"},{"key":"35","unstructured":"18) McLoughlin C., Statins.<\/i> Prof. Nurse<\/i>, 19<\/b>, 51–52 (2004)."},{"key":"36","unstructured":"18. McLoughlin C. Statins. Prof Nurse.<\/i>, 19, 51–52 (2004)."},{"key":"37","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2007.11.060"},{"key":"38","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2007.11.060"},{"key":"39","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-7258(03)00055-X"},{"key":"40","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-7258(03)00055-X"},{"key":"41","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-5273(02)00195-X"},{"key":"42","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-5273(02)00195-X"},{"key":"43","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aep361"},{"key":"44","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aep361"},{"key":"45","doi-asserted-by":"crossref","unstructured":"23) Libby P., Okamoto Y., Rocha V. Z., Folco E., Circ. J.<\/i>, 74<\/b>, 213–220 (2010).","DOI":"10.1253\/circj.CJ-09-0706"},{"key":"46","unstructured":"23. Libby P, Okamoto Y, Rocha VZ, Folco E. Inflammation in atherosclerosis: transition from theory to practice. Circ J.<\/i>, 74, 213–220 (2010)."},{"key":"47","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2009.55"},{"key":"48","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2009.55"},{"key":"49","doi-asserted-by":"crossref","unstructured":"25) Liu Y., Yan F., Liu Y., Zhang C., Yu H., Zhang Y., Zhao Y., Phytother. Res.<\/i>, 22<\/b>, 935–942 (2008).","DOI":"10.1002\/ptr.2429"},{"key":"50","doi-asserted-by":"crossref","unstructured":"25. Liu Y, Yan F, Liu Y, Zhang C, Yu H, Zhang Y, Zhao Y. Aqueous extract of rhubarb stabilizes vulnerable atherosclerotic plaques due to depression of inflammation and lipid accumulation. Phytother Res.<\/i>, 22, 935–942 (2008).","DOI":"10.1002\/ptr.2429"},{"key":"51","doi-asserted-by":"crossref","unstructured":"26) Arnaud J., Bost M., Vitoux D., Labarère J., Galan P., Faure H., Hercberg S., Bordet J. C., Roussel A. M., Chappuis P., Société Francophone d’Etudes et de Recherche sur les Eléments Toxiques et Essentiels, J. Am. Coll. Nutr.<\/i>, 26<\/b>, 405–411 (2007).","DOI":"10.1080\/07315724.2007.10719629"},{"key":"52","doi-asserted-by":"crossref","unstructured":"26. Arnaud J, Bost M, Vitoux D, Labarère J, Galan P, Faure H, Hercberg S, Bordet JC, Roussel AM, Chappuis P; Société Francophone d'Etudes et de Recherche sur les Eléments Toxiques et Essentiels. Effect of low dose antioxidant vitamin and trace element supplementation on the urinary concentrations of thromboxane and prostacyclin metabolites. J Am Coll Nutr.<\/i>, 26, 405–411 (2007).","DOI":"10.1080\/07315724.2007.10719629"},{"key":"53","doi-asserted-by":"crossref","unstructured":"27) Abela G. S., Picon P. D., Friedl S. E., Gebara O. C., Miyamoto A., Federman M., Tofler G. H., Muller J. E., Circulation<\/i>, 91<\/b>, 776–784 (1995).","DOI":"10.1161\/01.CIR.91.3.776"},{"key":"54","doi-asserted-by":"crossref","unstructured":"27. Abela GS, Picon PD, Friedl SE, Gebara OC, Miyamoto A, Federman M, Tofler GH, Muller JE. Triggering of plaque disruption and arterial thrombosis in an atherosclerotic rabbit model. Circulation.<\/i>, 91, 776–784 (1995).","DOI":"10.1161\/01.CIR.91.3.776"},{"key":"55","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000148955.19792.8D"},{"key":"56","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000148955.19792.8D"},{"key":"57","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000126186.29571.41"},{"key":"58","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000126186.29571.41"},{"key":"59","doi-asserted-by":"crossref","unstructured":"30) Jain M., Rosenberg M., Ann. Intern. Med.<\/i>, 157<\/b>, JC4–JC10 (2012).","DOI":"10.7326\/0003-4819-157-8-201210160-02002"},{"key":"60","unstructured":"30. Jain M, Rosenberg M. Meta-analysis: Lowering LDL-C levels using statins reduces major vascular events regardless of baseline risk. Ann Intern Med.<\/i>, 157, JC4–2 (2012)."},{"key":"61","unstructured":"31) Zbinden S., Brunner N., Wustmann K., Billinger M., Meier B., Seiler C., Heart<\/i>, 90<\/b>, 448–449 (2004)."},{"key":"62","doi-asserted-by":"crossref","unstructured":"31. Zbinden S, Brunner N, Wustmann K, Billinger M, Meier B, Seiler C. Effect of statin treatment on coronary collateral flow in patients with coronary artery disease. Heart.<\/i>, 90, 448–449 (2004).","DOI":"10.1136\/hrt.2003.017871"},{"key":"63","doi-asserted-by":"crossref","unstructured":"32) Gotto A. M. Jr., J. Am. Coll. Cardiol.<\/i>, 41<\/b>, 1205–1210 (2003).","DOI":"10.1016\/S0735-1097(03)00082-2"},{"key":"64","doi-asserted-by":"crossref","unstructured":"32. Gotto AM. Antioxidants, statins, and atherosclerosis. J Am Coll Cardiol.<\/i>, 41, 1205–1210 (2003).","DOI":"10.1016\/S0735-1097(03)00082-2"},{"key":"65","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(99)00525-2"},{"key":"66","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(99)00525-2"},{"key":"67","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M509292200"},{"key":"68","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M509292200"},{"key":"69","doi-asserted-by":"publisher","DOI":"10.1007\/s00380-010-0097-x"},{"key":"70","doi-asserted-by":"publisher","DOI":"10.1007\/s00380-010-0097-x"}],"container-title":["Chemical and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/cpb\/61\/2\/61_c12-00462\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T02:05:48Z","timestamp":1745373948000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/cpb\/61\/2\/61_c12-00462\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":70,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1248\/cpb.c12-00462","relation":{},"ISSN":["0009-2363","1347-5223"],"issn-type":[{"type":"print","value":"0009-2363"},{"type":"electronic","value":"1347-5223"}],"subject":[],"published":{"date-parts":[[2013]]}}}